Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03942874 · ClinicalTrials.gov registry record · NA
Development and Initial Tests of Reward Re-Training: A Novel Treatment For Reward Dysfunction
A NA study, sponsored by Drexel University.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT03942874 is a NA study that has completed, run by Drexel University. The registered enrollment target is 19 participants.
The verdict
NCT03942874, a NA study, has completed, sponsored by Drexel University.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to test a novel treatment for binge eating that will be compared to a waitlist control group. The investigators are seeking to target factors that might influence binge eating by increasing reward in non-food life domains. The treatment is weekly for 10 weeks and will take place at Drexel University in Philadelphia.
Interventions
- BEHAVIORAL Group Reward Retraining
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2019-04-24 |
| Est. Completion | 2019-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03942874
The ClinicalTrials.gov registry entry for NCT03942874 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Drexel University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Group Reward Retraining is the first listed.
NCT03942874 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03942874 about?
NCT03942874 is a clinical study titled "Development and Initial Tests of Reward Re-Training: A Novel Treatment For Reward Dysfunction". The purpose of this study is to test a novel treatment for binge eating that will be compared to a waitlist control group. The investigators are seeking to target factors that might influence binge eating by increasing reward in non-food life domains. The treatment is weekly for 10 weeks and will ta...
What is the current status of trial NCT03942874?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2019-04-24. Estimated completion is 2019-09-30.
What interventions are being tested in trial NCT03942874?
The interventions under investigation include: Group Reward Retraining (BEHAVIORAL).
Who is sponsoring clinical trial NCT03942874?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.